{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:49:29Z","timestamp":1787003369322,"version":"build-2736575974"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI171104"],"award-info":[{"award-number":["AI171104"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008590","name":"Dr. Ralph and Marian Falk Medical Research Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM007250"],"award-info":[{"award-number":["T32GM007250"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM135081"],"award-info":[{"award-number":["T32GM135081"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM007250"],"award-info":[{"award-number":["T32GM007250"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM007250"],"award-info":[{"award-number":["T32GM007250"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Harrington Discovery Institute accelerates promising discoveries into medicines for unmet needs"},{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["F30HD096784"],"award-info":[{"award-number":["F30HD096784"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1038\/s41589-024-01586-5","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T07:02:13Z","timestamp":1711350133000},"page":"1260-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting the chromatin binding of exportin-1 disrupts NFAT and T cell activation"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-4462","authenticated-orcid":false,"given":"Yi Fan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Ghazala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-9924","authenticated-orcid":false,"given":"Ryan M.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany A.","family":"Cordova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick N.","family":"Petroze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2919-4796","authenticated-orcid":false,"given":"David F.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel L.","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-3470","authenticated-orcid":false,"given":"Suzanne L.","family":"Tomchuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9513-8341","authenticated-orcid":false,"given":"Yuriy","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Y.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar B.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-336X","authenticated-orcid":false,"given":"Drew J.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"1586_CR1","first-page":"137","volume":"3","author":"KT Nguyen","year":"2012","unstructured":"Nguyen, K. T., Holloway, M. P. & Altura, R. A. The CRM1 nuclear export protein in normal development and disease. Int. J. Biochem. Mol. Biol. 3, 137\u2013151 (2012).","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-017-0412-4","volume":"10","author":"V Camus","year":"2017","unstructured":"Camus, V., Miloudi, H., Taly, A., Sola, B. & Jardin, F. XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy. J. Hematol. Oncol. 10, 47 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"9112","DOI":"10.1073\/pnas.96.16.9112","volume":"96","author":"N Kudo","year":"1999","unstructured":"Kudo, N. et al. Leptomycin B inactivates CRM1\/exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl Acad. Sci. USA 96, 9112\u20139117 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1586_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fphar.2020.00625","volume":"11","author":"BI Ferreira","year":"2020","unstructured":"Ferreira, B. I., Cautain, B., Grenho, I. & Link, W. Small molecule inhibitors of CRM1. Front. Pharm. 11, 625 (2020).","journal-title":"Front. Pharm."},{"key":"1586_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa1903455","volume":"381","author":"A Chari","year":"2019","unstructured":"Chari, A. et al. Oral selinexor-dexamethasone for triple-class refractory multiple myeloma. N. Engl. J. Med. 381, 727\u2013738 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1083\/jcb.108.4.1195","volume":"108","author":"Y Adachi","year":"1989","unstructured":"Adachi, Y. & Yanagida, M. Higher order chromosome structure is affected by cold-sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-kD protein preferentially localized in the nucleus and its periphery. J. Cell Biol. 108, 1195\u20131207 (1989).","journal-title":"J. Cell Biol."},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ncb1282","volume":"7","author":"W Wang","year":"2005","unstructured":"Wang, W., Budhu, A., Forgues, M. & Wang, X. W. Temporal and spatial control of nucleophosmin by the RAN\u2013CRM1 complex in centrosome duplication. Nat. Cell Biol. 7, 823\u2013830 (2005).","journal-title":"Nat. Cell Biol."},{"key":"1586_CR8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/sj.embor.7400824","volume":"7","author":"SK Knauer","year":"2006","unstructured":"Knauer, S. K., Bier, C., Habtemichael, N. & Stauber, R. H. The survivin\u2013CRM1 interaction is essential for chromosomal passenger complex localization and function. EMBO Rep. 7, 1259\u20131265 (2006).","journal-title":"EMBO Rep."},{"key":"1586_CR9","doi-asserted-by":"crossref","unstructured":"Oka, M. et al. Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto HOX clusters causing aberrant HOX expression in leukemia cells. eLife 8, e46667 (2019).","DOI":"10.7554\/eLife.46667"},{"key":"1586_CR10","doi-asserted-by":"publisher","first-page":"e09540","DOI":"10.7554\/eLife.09540","volume":"5","author":"M Oka","year":"2016","unstructured":"Oka, M. et al. Chromatin-prebound Crm1 recruits Nup98\u2013HoxA9 fusion to induce aberrant expression of Hox cluster genes. eLife 5, e09540 (2016).","journal-title":"eLife"},{"key":"1586_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1021\/jm970671g","volume":"41","author":"RW Sullivan","year":"1998","unstructured":"Sullivan, R. W. et al. 2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3\u2032,5\u2032-bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-\u03baB- and AP-1-mediated gene expression identified using solution-phase combinatorial chemistry. J. Med. Chem. 41, 413\u2013419 (1998).","journal-title":"J. Med. Chem."},{"key":"1586_CR12","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1016\/j.bmcl.2003.08.047","volume":"13","author":"MS Palanki","year":"2003","unstructured":"Palanki, M. S. et al. The design and synthesis of novel orally active inhibitors of AP-1 and NF-\u03baB mediated transcriptional activation. SAR of in vitro and in vivo studies. Bioorg. Med. Chem. Lett. 13, 4077\u20134080 (2003).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"1586_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev.iy.08.040190.002225","volume":"8","author":"KS Ullman","year":"1990","unstructured":"Ullman, K. S., Northrop, J. P., Verweij, C. L. & Crabtree, G. R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8, 421\u2013452 (1990).","journal-title":"Annu. Rev. Immunol."},{"key":"1586_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4889(00)00082-3","volume":"1498","author":"E Serfling","year":"2000","unstructured":"Serfling, E. et al. The role of NF-AT transcription factors in T cell activation and differentiation. Biochim. Biophys. Acta 1498, 1\u201318 (2000).","journal-title":"Biochim. Biophys. Acta"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41577-019-0203-y","volume":"20","author":"NM Chapman","year":"2020","unstructured":"Chapman, N. M., Boothby, M. R. & Chi, H. Metabolic coordination of T cell quiescence and activation. Nat. Rev. Immunol. 20, 55\u201370 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/sj.onc.1204386","volume":"20","author":"F Macian","year":"2001","unstructured":"Macian, F., Lopez-Rodriguez, C. & Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 20, 2476\u20132489 (2001).","journal-title":"Oncogene"},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser, R. & Blazar, B. R. Acute graft-versus-host disease\u2014biologic process, prevention, and therapy. N. Engl. J. Med. 377, 2167\u20132179 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1586_CR18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","volume":"11","author":"M Zhang","year":"2020","unstructured":"Zhang, M. & Zhang, S. T cells in fibrosis and fibrotic diseases. Front. Immunol. 11, 1142 (2020).","journal-title":"Front. Immunol."},{"key":"1586_CR19","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.2174\/0929867327666201006153202","volume":"28","author":"J Patocka","year":"2021","unstructured":"Patocka, J., Nepovimova, E., Kuca, K. & Wu, W. Cyclosporine A: chemistry and toxicity\u2014a review. Curr. Med. Chem. 28, 3925\u20133934 (2021).","journal-title":"Curr. Med. Chem."},{"key":"1586_CR20","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S0041-1345(96)00492-7","volume":"29","author":"M Morikawa","year":"1997","unstructured":"Morikawa, M., Shorthouse, R. A., Suto, M. J., Goldman, M. E. & Morris, R. E. A novel inhibitor of nuclear factor-\u03baB and activator protein-1 transcription factors in T cells suppresses host-versus-graft alloreactivity in vivo. Transpl. Proc. 29, 1269\u20131270 (1997).","journal-title":"Transpl. Proc."},{"key":"1586_CR21","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.4049\/jimmunol.165.3.1652","volume":"165","author":"DM Gerlag","year":"2000","unstructured":"Gerlag, D. M. et al. The effect of a T cell-specific NF-\u03baB inhibitor on in vitro cytokine production and collagen-induced arthritis. J. Immunol. 165, 1652\u20131658 (2000).","journal-title":"J. Immunol."},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1164\/rccm.200609-1288OC","volume":"176","author":"H Fujimoto","year":"2007","unstructured":"Fujimoto, H. et al. Inhibition of nuclear factor-\u03baB in T cells suppresses lung fibrosis. Am. J. Respir. Crit. Care Med. 176, 1251\u20131260 (2007).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1586_CR23","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1021\/jm0001626","volume":"43","author":"MS Palanki","year":"2000","unstructured":"Palanki, M. S. et al. Inhibitors of NF-\u03baB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3\u2032,5\u2032-bis(trifluoromethyl)phenyl)carboxamide]. J. Med. Chem. 43, 3995\u20134004 (2000).","journal-title":"J. Med. Chem."},{"key":"1586_CR24","first-page":"3106","volume":"28","author":"ME Goldman","year":"1996","unstructured":"Goldman, M. E. et al. SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo. Transpl. Proc. 28, 3106\u20133109 (1996).","journal-title":"Transpl. Proc."},{"key":"1586_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/sj.bjp.0704344","volume":"134","author":"TJ Huang","year":"2001","unstructured":"Huang, T. J., Adcock, I. M. & Chung, K. F. A novel transcription factor inhibitor, SP100030, inhibits cytokine gene expression, but not airway eosinophilia or hyperresponsiveness in sensitized and allergen-exposed rat. Br. J. Pharmacol. 134, 1029\u20131036 (2001).","journal-title":"Br. J. Pharmacol."},{"key":"1586_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev-immunol-042617-053352","volume":"36","author":"SH Ross","year":"2018","unstructured":"Ross, S. H. & Cantrell, D. A. Signaling and function of interleukin-2 in T lymphocytes. Annu. Rev. Immunol. 36, 411\u2013433 (2018).","journal-title":"Annu. Rev. Immunol."},{"key":"1586_CR27","doi-asserted-by":"publisher","first-page":"68842","DOI":"10.18632\/oncotarget.11995","volume":"7","author":"JE Neggers","year":"2016","unstructured":"Neggers, J. E. et al. Heterozygous mutation of cysteine528 in XPO1 is sufficient for resistance to selective inhibitors of nuclear export. Oncotarget 7, 68842\u201368850 (2016).","journal-title":"Oncotarget"},{"key":"1586_CR28","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/cbic.202100038","volume":"22","author":"JG Martin","year":"2021","unstructured":"Martin, J. G. et al. Chemoproteomic profiling of covalent XPO1 inhibitors to assess target engagement and selectivity. ChemBioChem 22, 2116\u20132123 (2021).","journal-title":"ChemBioChem"},{"key":"1586_CR29","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1080\/15384047.2015.1047569","volume":"16","author":"M Niu","year":"2015","unstructured":"Niu, M., Chong, Y., Han, Y. & Liu, X. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells. Cancer Biol. Ther. 16, 1110\u20131118 (2015).","journal-title":"Cancer Biol. Ther."},{"key":"1586_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41589-021-00865-9","volume":"17","author":"AM Freedy","year":"2021","unstructured":"Freedy, A. M. & Liau, B. B. Discovering new biology with drug-resistance alleles. Nat. Chem. Biol. 17, 1219\u20131229 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"1586_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/leu.2013.115","volume":"28","author":"YT Tai","year":"2014","unstructured":"Tai, Y. T. et al. CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications. Leukemia 28, 155\u2013165 (2014).","journal-title":"Leukemia"},{"key":"1586_CR32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1074\/mcp.M112.024877","volume":"12","author":"K Thakar","year":"2013","unstructured":"Thakar, K., Karaca, S., Port, S. A., Urlaub, H. & Kehlenbach, R. H. Identification of CRM1-dependent nuclear export cargos using quantitative mass spectrometry. Mol. Cell Proteom. 12, 664\u2013678 (2013).","journal-title":"Mol. Cell Proteom."},{"key":"1586_CR33","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1101\/gad.1267105","volume":"19","author":"J Dai","year":"2005","unstructured":"Dai, J., Sultan, S., Taylor, S. S. & Higgins, J. M. The kinase haspin is required for mitotic histone H3 Thr\u20093 phosphorylation and normal metaphase chromosome alignment. Genes Dev. 19, 472\u2013488 (2005).","journal-title":"Genes Dev."},{"key":"1586_CR34","doi-asserted-by":"publisher","first-page":"21529","DOI":"10.1074\/jbc.M100014200","volume":"276","author":"Y Tokuyama","year":"2001","unstructured":"Tokuyama, Y., Horn, H. F., Kawamura, K., Tarapore, P. & Fukasawa, K. Specific phosphorylation of nucleophosmin on Thr199 by cyclin-dependent kinase 2-cyclin E and its role in centrosome duplication. J. Biol. Chem. 276, 21529\u201321537 (2001).","journal-title":"J. Biol. Chem."},{"key":"1586_CR35","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/nprot.2018.015","volume":"13","author":"PJ Skene","year":"2018","unstructured":"Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006\u20131019 (2018).","journal-title":"Nat. Protoc."},{"key":"1586_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nri1632","volume":"5","author":"F Macian","year":"2005","unstructured":"Macian, F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5, 472\u2013484 (2005).","journal-title":"Nat. Rev. Immunol."},{"key":"1586_CR37","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1242\/dmm.006668","volume":"4","author":"MA Schroeder","year":"2011","unstructured":"Schroeder, M. A. & DiPersio, J. F. Mouse models of graft-versus-host disease: advances and limitations. Dis. Model Mech. 4, 318\u2013333 (2011).","journal-title":"Dis. Model Mech."},{"key":"1586_CR38","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1182\/blood-2009-06-229708","volume":"115","author":"T Toubai","year":"2010","unstructured":"Toubai, T. et al. Immunization with host-type CD8\u03b1+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner. Blood 115, 724\u2013735 (2010).","journal-title":"Blood"},{"key":"1586_CR39","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1038\/s41375-020-0756-6","volume":"34","author":"M Gavriatopoulou","year":"2020","unstructured":"Gavriatopoulou, M. et al. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials. Leukemia 34, 2430\u20132440 (2020).","journal-title":"Leukemia"},{"key":"1586_CR40","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1073\/pnas.1215214110","volume":"110","author":"T Monecke","year":"2013","unstructured":"Monecke, T. et al. Structural basis for cooperativity of CRM1 export complex formation. Proc. Natl Acad. Sci. USA 110, 960\u2013965 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1586_CR41","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1091\/mbc.E18-02-0096","volume":"29","author":"SC Fu","year":"2018","unstructured":"Fu, S. C., Fung, H. Y. J., Cagatay, T., Baumhardt, J. & Chook, Y. M. Correlation of CRM1-NES affinity with nuclear export activity. Mol. Biol. Cell 29, 2037\u20132044 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"1586_CR42","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nature07975","volume":"458","author":"X Dong","year":"2009","unstructured":"Dong, X. et al. Structural basis for leucine-rich nuclear export signal recognition by CRM1. Nature 458, 1136\u20131141 (2009).","journal-title":"Nature"},{"key":"1586_CR43","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.18632\/oncotarget.6495","volume":"7","author":"ML Crochiere","year":"2016","unstructured":"Crochiere, M. L. et al. A method for quantification of exportin-1 (XPO1) occupancy by selective inhibitor of nuclear export (SINE) compounds. Oncotarget 7, 1863\u20131877 (2016).","journal-title":"Oncotarget"},{"key":"1586_CR44","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/18473","volume":"398","author":"J Zhu","year":"1999","unstructured":"Zhu, J. & McKeon, F. NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature 398, 256\u2013260 (1999).","journal-title":"Nature"},{"key":"1586_CR45","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41573-022-00505-4","volume":"21","author":"DM Mitrea","year":"2022","unstructured":"Mitrea, D. M., Mittasch, M., Gomes, B. F., Klein, I. A. & Murcko, M. A. Modulating biomolecular condensates: a novel approach to drug discovery. Nat. Rev. Drug Discov. 21, 841\u2013862 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1586_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"1586_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"1586_CR48","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"1586_CR49","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1101\/gr.193540.115","volume":"25","author":"D Savic","year":"2015","unstructured":"Savic, D. et al. CETCh-seq: CRISPR epitope tagging ChIP\u2013seq of DNA-binding proteins. Genome Res. 25, 1581\u20131589 (2015).","journal-title":"Genome Res."},{"key":"1586_CR50","doi-asserted-by":"publisher","first-page":"W187","DOI":"10.1093\/nar\/gku365","volume":"42","author":"F Ramirez","year":"2014","unstructured":"Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187\u2013W191 (2014).","journal-title":"Nucleic Acids Res."},{"key":"1586_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","volume":"12","author":"MP Meers","year":"2019","unstructured":"Meers, M. P., Tenenbaum, D. & Henikoff, S. Peak calling by sparse enrichment analysis for CUT&RUN chromatin profiling. Epigenetics Chromatin 12, 42 (2019).","journal-title":"Epigenetics Chromatin"},{"key":"1586_CR52","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.1630","volume":"28","author":"CY McLean","year":"2010","unstructured":"McLean, C. Y. et al. GREAT improves functional interpretation of cis-regulatory regions. Nat. Biotechnol. 28, 495\u2013501 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1586_CR53","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"1586_CR54","doi-asserted-by":"publisher","first-page":"e1002529","DOI":"10.1371\/journal.pcbi.1002529","volume":"8","author":"A Favorov","year":"2012","unstructured":"Favorov, A. et al. Exploring massive, genome scale datasets with the GenometriCorr package. PLoS Comput. Biol. 8, e1002529 (2012).","journal-title":"PLoS Comput. Biol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01586-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01586-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T13:03:24Z","timestamp":1727355804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-024-01586-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1038\/s41589-024-01586-5","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"assertion":[{"value":"13 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.F.C., R.S., D.F.Y. and D.J.A. are inventors on a provisional patent (63\/627,975) filed by Case Western Reserve University on the synthesis of small molecules, their analogs and their derivatives that target XPO1 to suppress T cell activation with minimal cytotoxicity. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}